The AACR 2026 abstract tabulated below presents 1L combination of daraxonrasib and GnP. Encouraging results, despite the safety profile, deemed manageable, revealing increased toxicity to the regimen.
https://acrobat.adobe.com/id/urn:aaid:sc:AP:4a8ad0cd-8e5b-
4aea-af88-36a82241d280![]()
The AACR 2026 abstract tabulated below presents 1L combination...
Add to My Watchlist
What is My Watchlist?
